Find Tunlametinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Tunlametinib [inn], If25nr1pv3, 1801756-06-8, Unii-if25nr1pv3, Hl085, Hl-085
Molecular Formula
C16H12F2IN3O3S
Molecular Weight
491.3  g/mol
InChI Key
UFZJUVFSSINETF-UHFFFAOYSA-N
FDA UNII
IF25NR1PV3

Tunlametinib
Tunlametinib is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MAP2K, MAPK/ERK kinase, or MEK), with potential antineoplastic activity. Upon administration, tunlametinib selectively binds to and inhibits the activity of MEK, preventing the activation of MEK-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK, a threonine/tyrosine kinase, plays a key role in the activation of the RAS/RAF/MEK/ERK pathway that regulates cell growth. This pathway is often dysregulated in a variety of tumor cell types through BRAF, KRAS and NRAS mutations.
1 2D Structure

Tunlametinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-fluoro-5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,3-benzothiazole-6-carboxamide
2.1.2 InChI
InChI=1S/C16H12F2IN3O3S/c17-10-5-8(19)1-2-11(10)21-14-9(16(24)22-25-4-3-23)6-12-15(13(14)18)20-7-26-12/h1-2,5-7,21,23H,3-4H2,(H,22,24)
2.1.3 InChI Key
UFZJUVFSSINETF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C=C1I)F)NC2=C(C3=C(C=C2C(=O)NOCCO)SC=N3)F
2.2 Other Identifiers
2.2.1 UNII
IF25NR1PV3
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Tunlametinib [inn]

2. If25nr1pv3

3. 1801756-06-8

4. Unii-if25nr1pv3

5. Hl085

6. Hl-085

7. 4-fluoro-5-((2-fluoro-4-iodophenyl)amino)-n-(2-hydroxyethoxy)-6-benzothiazolecarboxamide

8. 6-benzothiazolecarboxamide, 4-fluoro-5-((2-fluoro-4-iodophenyl)amino)-n-(2-hydroxyethoxy)-

9. 4-fluoro-5-(2-fluoro-4-iodoanilino)-n-(2-hydroxyethoxy)-1,3-benzothiazole-6-carboxamide

10. Chembl5095241

11. Hl 085 [who-dd]

12. Schembl15129499

13. Gtpl11675

14. Hl 085

15. Ufzjuvfssinetf-uhfffaoysa-n

16. Akos040757035

17. Example 9 [wo2013107283a1]

18. Hy-132844

19. Cs-0204149

20. 4-fluoro-5-((2-fluoro-4-iodophenyl)amino)-n-(2-hydroxyethoxy)benzo[d]thiazole-6-carboxamide

2.4 Create Date
2013-08-05
3 Chemical and Physical Properties
Molecular Weight 491.3 g/mol
Molecular Formula C16H12F2IN3O3S
XLogP34
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area112
Heavy Atom Count26
Formal Charge0
Complexity496
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 1801756-06-8 / Tunlametinib API manufacturers, exporters & distributors?

Tunlametinib manufacturers, exporters & distributors 1

100

PharmaCompass offers a list of Tunlametinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tunlametinib manufacturer or Tunlametinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tunlametinib manufacturer or Tunlametinib supplier.

PharmaCompass also assists you with knowing the Tunlametinib API Price utilized in the formulation of products. Tunlametinib API Price is not always fixed or binding as the Tunlametinib Price is obtained through a variety of data sources. The Tunlametinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Tunlametinib

Synonyms

Tunlametinib [inn], If25nr1pv3, 1801756-06-8, Unii-if25nr1pv3, Hl085, Hl-085

Cas Number

1801756-06-8

Unique Ingredient Identifier (UNII)

IF25NR1PV3

About Tunlametinib

Tunlametinib is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MAP2K, MAPK/ERK kinase, or MEK), with potential antineoplastic activity. Upon administration, tunlametinib selectively binds to and inhibits the activity of MEK, preventing the activation of MEK-dependent effector proteins and transcription factors, which may result in the inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK, a threonine/tyrosine kinase, plays a key role in the activation of the RAS/RAF/MEK/ERK pathway that regulates cell growth. This pathway is often dysregulated in a variety of tumor cell types through BRAF, KRAS and NRAS mutations.

Tunlametinib Manufacturers

A Tunlametinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tunlametinib, including repackagers and relabelers. The FDA regulates Tunlametinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tunlametinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Tunlametinib Suppliers

A Tunlametinib supplier is an individual or a company that provides Tunlametinib active pharmaceutical ingredient (API) or Tunlametinib finished formulations upon request. The Tunlametinib suppliers may include Tunlametinib API manufacturers, exporters, distributors and traders.

Tunlametinib GMP

Tunlametinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Tunlametinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tunlametinib GMP manufacturer or Tunlametinib GMP API supplier for your needs.

Tunlametinib CoA

A Tunlametinib CoA (Certificate of Analysis) is a formal document that attests to Tunlametinib's compliance with Tunlametinib specifications and serves as a tool for batch-level quality control.

Tunlametinib CoA mostly includes findings from lab analyses of a specific batch. For each Tunlametinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Tunlametinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Tunlametinib EP), Tunlametinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tunlametinib USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty